Breakfast Briefing with Ian Chapman, Chief Executive Officer, UK Research and Innovation

Key Takeaways: 

Strategic Insights and Thematic Analysis 

Ian Chapman's opening address set a deliberately macro frame: the UK's research base is not merely a public good but the country's primary differentiable asset in a global growth competition where it lacks the natural resources, land mass or cheap energy that advantage many G7 peers. The session explored whether UKRI's reforms are sufficient to translate that asset into GDP growth, and what remains structurally unresolved. 

The Research-to-Growth Gap 

There was broad consensus in the room that the UK's research standing is exceptional and underappreciated as an economic instrument. Chapman cited the UK's position as the world's most sought-after collaborative research partner and its highest field-weighted citation index globally, achievements he described as "astonishing" for a medium-sized economy. The more uncomfortable finding, however, is the persistent decoupling between R&D investment and economic growth: the research budget has risen over 50% in real terms since the financial crisis, yet national growth has broadly flatlined over the same period. 

Participants acknowledged that causality is difficult to establish, with EU exit and other structural factors compounding the picture. The more pointed challenge raised was one of translation: the UK has consistently generated world-class research without building the portfolio curation, marketing infrastructure or capital connectivity needed to convert that research into high-growth companies and sectors. The current Industrial Strategy was described as the closest the country has come to framing this as a matter of economic security rather than academic prestige, a framing that competitors have adopted explicitly for decades. 

Structural Reform: Funding by Outcome, Not Discipline 

The most significant operational shift discussed was UKRI's reorganisation of its entire budget into three outcome-based buckets: curiosity-driven Discovery Science; societal priorities aligned to Industrial Strategy sectors; and support for companies to start and scale. This replaces a model in which money was routed by discipline: engineering, medical research, arts and humanities, with one in which disciplines are brought together to achieve defined outcomes. 

Chapman used AI funding as the clearest illustration of why this matters. Previously split across 14 separate budget holders, any substantive AI initiative required alignment across all 14, making large, multi-disciplinary bets effectively impossible. Consolidation removes that structural blockage. Assessment criteria are also being differentiated by bucket: Discovery Science will be evaluated on novelty and excellence almost exclusively, while company-focused investment will weight additionality, team track record and leverage of other capital. 

Innovate UK and the Commercialisation Challenge 

The repositioning of Innovate UK as a horizontal, portfolio-managing commercialisation engine was presented as one of the most consequential elements of the reform programme. The diagnosis driving it is stark: the UK has historically allowed high-quality, internationally differentiated research to be born into thousands of small companies, each independently approaching venture capital and pension funds, producing what Chapman described as "white noise" to scale investors. No single company is visible enough; no curated portfolio exists to present. 

The aspiration is to create an investable vehicle, with UKRI providing portfolio visibility and due diligence across the whole UK research base, the British Business Bank and National Wealth Fund as cornerstone capital, and pension funds and sovereign wealth funds as scale investors. Innovate UK, reoriented as a horizontal function, would identify high-growth-potential research before it reaches market readiness and accompany companies on a structured journey, replacing discrete grants with "cliff edges" with a curated, concierge-style model in which continued funding is tied to milestones rather than repeated competitive applications. 

Procurement as an Economic Pull-Through 

A substantive thread running through audience questions concerned the role of public procurement in creating the guaranteed demand that enables early-stage companies to raise private capital. Chapman described the Research and Development Commissions Accelerator programme as an early model: working with Whitehall departments to define precise research challenges and secure pre-commitments to purchase at a defined specification.  

Regional Investment and Place-Based Focus 

UKRI's share of investment going outside Greater London and the South East has risen from approximately 12% to over 20% in five years, ahead of the cross-Whitehall average. However, Chapman was candid that this has not been locally felt proportionate to the investment, because it has been dispersed too broadly across too many sectors and places simultaneously. The Local Innovation Partnerships programme represents a deliberate correction: co-creating with Mayoral Strategic Authorities, local mayors and devolved administrations to identify one or two areas of genuine international competitive potential, then concentrating multiple funding streams: infrastructure, skills, innovation. 

Examples cited included Plymouth anchoring on unmanned maritime systems for defence applications, and the Tay region in Scotland focusing on the creative sector and video games. The underlying principle was broadly endorsed, though participants acknowledged the political difficulty of place-based prioritisation when regions are competing for investment recognition.